Published in Isr J Health Policy Res on June 15, 2016
Comparative efficacy and tolerability of 15 antipsychotic drugs in schizophrenia: a multiple-treatments meta-analysis. Lancet (2013) 8.20
Clozapine, olanzapine, risperidone, and haloperidol in the treatment of patients with chronic schizophrenia and schizoaffective disorder. Am J Psychiatry (2002) 5.14
New users of antipsychotic medications among children enrolled in TennCare. Arch Pediatr Adolesc Med (2004) 2.80
Antipsychotics in adults with schizophrenia: comparative effectiveness of first-generation versus second-generation medications: a systematic review and meta-analysis. Ann Intern Med (2012) 2.52
Evidence-based guidelines for treating bipolar disorder: revised second edition--recommendations from the British Association for Psychopharmacology. J Psychopharmacol (2009) 2.48
Increasing off-label use of antipsychotic medications in the United States, 1995-2008. Pharmacoepidemiol Drug Saf (2011) 2.38
Broadened use of atypical antipsychotics: safety, effectiveness, and policy challenges. Health Aff (Millwood) (2009) 2.29
Risperidone in the treatment of patients with chronic schizophrenia: a multi-national, multi-centre, double-blind, parallel-group study versus haloperidol. Risperidone Study Group. Br J Psychiatry (1995) 2.29
Quetiapine in patients with schizophrenia. A high- and low-dose double-blind comparison with placebo. Seroquel Study Group. Arch Gen Psychiatry (1997) 2.26
How effective are second-generation antipsychotic drugs? A meta-analysis of placebo-controlled trials. Mol Psychiatry (2008) 2.23
Antipsychotic prescribing trends: a review of pharmaco-epidemiological studies. Acta Psychiatr Scand (2009) 2.07
A double-blind, placebo-controlled dose-response comparison of intramuscular olanzapine and haloperidol in the treatment of acute agitation in schizophrenia. Arch Gen Psychiatry (2002) 1.97
Patterns of antipsychotic medication use in Australia 2002-2007. Aust N Z J Psychiatry (2010) 1.86
Paliperidone for schizophrenia. Cochrane Database Syst Rev (2008) 1.45
Update on typical and atypical antipsychotic drugs. Annu Rev Med (2012) 1.38
Trends in the utilisation of psychotropic medications in Australia from 2000 to 2011. Aust N Z J Psychiatry (2012) 1.31
Pharmacological management of bipolar depression: acute treatment, maintenance, and prophylaxis. CNS Drugs (2013) 1.07
Optimal dosing of atypical antipsychotics in adults: a review of the current evidence. Harv Rev Psychiatry (2002) 1.04
Medication for psychosis--consumption and consequences: the second Australian national survey of psychosis. Aust N Z J Psychiatry (2012) 0.96
Augmentation with atypical antipsychotics for depression: a review of evidence-based support from the medical literature. Pharmacotherapy (2013) 0.94
Antipsychotic drug use: McLean Hospital, 2002. Hum Psychopharmacol (2005) 0.92
The cost effectiveness of long-acting/extended-release antipsychotics for the treatment of schizophrenia: a systematic review of economic evaluations. Appl Health Econ Health Policy (2013) 0.92
Promises and pitfalls on the road to a mental health reform in Israel. Isr J Psychiatry Relat Sci (2010) 0.90
Trends in prescribing of psychotropic medications for inpatient adolescents in Israel: a 10 years retrospective analysis. Eur Psychiatry (2011) 0.90
Polypharmacy with antipsychotic drugs in patients with schizophrenia: trends in multiple health care systems. Am J Health Syst Pharm (2014) 0.88
Changes in medication practices for hospitalized psychiatric patients: 2009 versus 2004. Hum Psychopharmacol (2010) 0.85
Trends in consumption of psychiatric drugs in Serbia and Montenegro 2000-2004. Pharmacoepidemiol Drug Saf (2006) 0.84
Trends in antipsychotic prescribing in schizophrenia in Auckland. Australas Psychiatry (2006) 0.80
Antipsychotic monotherapy and polypharmacy in the treatment of outpatients with schizophrenia in the European Schizophrenia Outpatient Health Outcomes Study. J Nerv Ment Dis (2012) 0.79
Predictors of antipsychotic monotherapy with olanzapine during a 1-year naturalistic study of schizophrenia patients in Japan. Clinicoecon Outcomes Res (2012) 0.77
Prevalence and correlates of "high dose" antipsychotic prescribing: findings from a hospital audit. Ann Med Health Sci Res (2013) 0.77